查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585685

双磷酸盐药品市场：依治疗领域、给药方式、应用、通路 - 2025-2030 年全球预测

Bisphosphonates Market by Therapeutic Areas (Cancer, Degenerative Bone Diseases), Mode of Delivery (Intravenous, Oral), Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年双磷酸盐药品市值为24.6亿美元，预计到2024年将达到25.5亿美元，复合年增长率为3.75%，到2030年将达到31.8亿美元。

双磷酸盐药物是一类用于预防和治疗骨质疏鬆症和类似骨相关疾病的药物，主要透过抑制骨吸收和更新。世界人口老化以及骨质疏鬆症和其他骨骼病患病率的上升加剧了这项需求。应用范围广泛，包括治疗停经后妇女的骨质疏鬆症、预防接受慢性类固醇治疗的患者骨折、治疗癌症患者的骨转移。最终用途包括医院、诊所和家庭保健。影响成长的关键因素包括骨质疏鬆症管理意识的提高、药物配方的进步以及医疗保健支出的增加。新的商机在于双磷酸盐药物在罕见骨骼疾病治疗中的扩大使用，以及缓释性製剂等药物传递系统的潜在开发，以提高患者的依从性。然而，阻碍生长的挑战包括胃肠道疾病和下颚骨坏死等副作用，以及严格的监管调整，这可能会延迟新药的推出。由于替代疗法（包括新生物製药和单株抗体）的竞争也存在局限性，这可能促使双磷酸盐的使用需要进一步创新。在创新方面，存在机会研究具有更高功效和减少副作用的双磷酸盐类似物，以及探索可能具有协同效应的联合治疗方法。此外，可以即时了解患者​​依从性和反应的数位健康监测工具可以补充双磷酸盐治疗。该市场竞争激烈，其特点是製药公司、学术界进行新研究以及在许可和联盟方面采取战略倡议的公司之间的合作。注重产品创新和交付方法的改进对于获得市场占有率至关重要。此外，您可以透过快速回应监管变化并透过策略规划解决新的竞争威胁来显着增强您的市场地位。

主要市场统计
基准年[2023] 24.6亿美元
预测年份 [2024] 25.5亿美元
预测年份 [2030] 31.8亿美元
复合年增长率（%） 3.75%

市场动态：快速发展的双磷酸盐药物市场的关键市场洞察

双磷酸盐药物市场正因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 各国老化率不断上升
    • 加大投资改善医疗基础设施
    • 改善报销政策和医疗保健服务
  • 市场限制因素
    • 双磷酸盐类药物的不良反应
  • 市场机会
    • 脊椎融合手术数量增加
    • 开发新药领域的研究与开发
  • 市场挑战
    • 意识淡薄，缺乏熟练的专业人员

波特五力：驾驭双磷酸盐药物市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解双磷酸盐药物市场的外部影响

外部宏观环境因素在塑造双磷酸盐药物市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解双磷酸盐药物市场的竞争格局

对双磷酸盐药品市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵双磷酸盐药品市场供应商的绩效评估

FPNV定位矩阵是评估双磷酸盐药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了双磷酸盐药物市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对双磷酸盐药品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 经济老化率上升
      • 加大投资改善医疗基础设施
      • 改善报销政策和医疗保健服务
    • 抑制因素
      • 双磷酸盐类药物的不良反应
    • 机会
      • 脊椎融合手术增加
      • 开发新药领域的研究与开发
    • 任务
      • 意识淡薄，缺乏熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依治疗领域分類的双磷酸盐药物市场

  • 癌症
    • 乳癌
    • 骨髓瘤
  • 骨退化性疾病
    • 低血钙
    • 骨质疏鬆症

第七章 依给药方式分類的双磷酸盐药物市场

  • 静脉
  • 口服

第八章双磷酸盐药品市场：依应用分类

  • 妇科
  • 肿瘤学
  • 整形外科

第九章双磷酸盐药品市场：依通路

  • 医院
  • 线上管道
  • 零售药房

第十章美洲双磷酸盐药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太双磷酸盐药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲双磷酸盐药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Apotex Inc.
  • Asahi Kasei Corp.
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
Product Code: MRR-437D45957DAF

The Bisphosphonates Market was valued at USD 2.46 billion in 2023, expected to reach USD 2.55 billion in 2024, and is projected to grow at a CAGR of 3.75%, to USD 3.18 billion by 2030.

Bisphosphonates are a class of drugs primarily used to prevent and treat osteoporosis and similar bone-related conditions by inhibiting bone resorption and turnover. Their necessity is underscored by an aging global population and rising prevalence of osteoporosis and other bone diseases. The application scopes span across treating osteoporosis in postmenopausal women, preventing fractures in patients undergoing chronic steroid therapy, and addressing bone metastases in cancer patients. End-use scopes involve hospitals, clinics, and home healthcare settings. Key factors influencing growth include increasing awareness of osteoporosis management, advancements in drug formulations, and growing healthcare expenditure. Emerging opportunities lie in expanding applications for bisphosphonates in treating rare bone disorders and potential developments in drug delivery systems, such as extended-release formulations, to enhance patient compliance. However, challenges that impede growth include side effects like gastrointestinal issues, jaw osteonecrosis, and stringent regulatory adjustments, potentially delaying the introduction of new drug varieties. Limitations also arise from competition with alternative therapies, including newer biologics and monoclonal antibodies, possibly driving a need for further innovation in bisphosphonate use. In terms of innovation, opportunities exist in researching bisphosphonate analogs with enhanced efficacy and reduced side effects, and exploring combination therapy approaches that might offer synergistic benefits. Moreover, digital health monitoring tools providing real-time insights into patient adherence and response could complement bisphosphonate therapy. The market nature is highly competitive and is characterized by collaboration among pharmaceutical companies, academia for novel research, and entities making strategic moves in licensing and partnerships. Emphasis on both product innovation and enhanced delivery methods is essential for capturing market share. Moreover, adapting to regulatory changes swiftly and addressing emerging competitive threats through strategic planning can significantly bolster market positions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.46 billion
Estimated Year [2024] USD 2.55 billion
Forecast Year [2030] USD 3.18 billion
CAGR (%) 3.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bisphosphonates Market

The Bisphosphonates Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing rate of aging population in economies
    • Rising investments to improve healthcare infrastructure
    • Improving reimbursement policies and healthcare access
  • Market Restraints
    • Adverse effects of bisphosphonates
  • Market Opportunities
    • Rising number of spine fusion surgeries
    • R&D in the arena of novel drugs development
  • Market Challenges
    • Limited awareness and dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Bisphosphonates Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bisphosphonates Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bisphosphonates Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bisphosphonates Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bisphosphonates Market

A detailed market share analysis in the Bisphosphonates Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bisphosphonates Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bisphosphonates Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bisphosphonates Market

A strategic analysis of the Bisphosphonates Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bisphosphonates Market, highlighting leading vendors and their innovative profiles. These include Apotex Inc., Asahi Kasei Corp., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd., Genentech, Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Bisphosphonates Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapeutic Areas, market is studied across Cancer and Degenerative Bone Diseases. The Cancer is further studied across Breast Cancer and Myeloma. The Degenerative Bone Diseases is further studied across Hypocalcemia and Osteoporosis.
  • Based on Mode of Delivery, market is studied across Intravenous and Oral.
  • Based on Application, market is studied across Gynecology, Oncology, and Orthopedics.
  • Based on Distribution Channel, market is studied across Hospitals, Online Channels, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing rate of aging population in economies
      • 5.1.1.2. Rising investments to improve healthcare infrastructure
      • 5.1.1.3. Improving reimbursement policies and healthcare access
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects of bisphosphonates
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising number of spine fusion surgeries
      • 5.1.3.2. R&D in the arena of novel drugs development
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and dearth of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bisphosphonates Market, by Therapeutic Areas

  • 6.1. Introduction
  • 6.2. Cancer
    • 6.2.1. Breast Cancer
    • 6.2.2. Myeloma
  • 6.3. Degenerative Bone Diseases
    • 6.3.1. Hypocalcemia
    • 6.3.2. Osteoporosis

7. Bisphosphonates Market, by Mode of Delivery

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Oral

8. Bisphosphonates Market, by Application

  • 8.1. Introduction
  • 8.2. Gynecology
  • 8.3. Oncology
  • 8.4. Orthopedics

9. Bisphosphonates Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Online Channels
  • 9.4. Retail Pharmacies

10. Americas Bisphosphonates Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Bisphosphonates Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Bisphosphonates Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apotex Inc.
  • 2. Asahi Kasei Corp.
  • 3. Dr. Reddy's Laboratories Ltd.
  • 4. F. Hoffmann-La Roche Ltd.
  • 5. Genentech, Inc.
  • 6. Merck KGaA
  • 7. Novartis AG
  • 8. Pfizer Inc.
  • 9. Sanofi S.A.

LIST OF FIGURES

  • FIGURE 1. BISPHOSPHONATES MARKET RESEARCH PROCESS
  • FIGURE 2. BISPHOSPHONATES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BISPHOSPHONATES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BISPHOSPHONATES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BISPHOSPHONATES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BISPHOSPHONATES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BISPHOSPHONATES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BISPHOSPHONATES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BISPHOSPHONATES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BISPHOSPHONATES MARKET DYNAMICS
  • TABLE 7. GLOBAL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BISPHOSPHONATES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BISPHOSPHONATES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BISPHOSPHONATES MARKET SIZE, BY HYPOCALCEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BISPHOSPHONATES MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BISPHOSPHONATES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BISPHOSPHONATES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BISPHOSPHONATES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BISPHOSPHONATES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BISPHOSPHONATES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BISPHOSPHONATES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 120. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. TAIWAN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 132. THAILAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. VIETNAM BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BISPHOSPHONATES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 151. DENMARK BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. EGYPT BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. FINLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. FRANCE BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 175. GERMANY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. ISRAEL BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 187. ITALY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 199. NIGERIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 205. NORWAY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. POLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 217. QATAR BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. RUSSIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 229. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 241. SPAIN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SWEDEN BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 259. TURKEY BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY THERAPEUTIC AREAS, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY DEGENERATIVE BONE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BISPHOSPHONATES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 277. BISPHOSPHONATES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 278. BISPHOSPHONATES MARKET, FPNV POSITIONING MATRIX, 2023